C3 Prize

Astellas Oncology Announces 2019 C3 Prize® Finalists

Summary: 
  • Finalists will present their ideas during a live pitch event
  • $200,000 in total funds to be awarded
Press Release
  • Finalists will present their ideas during a live pitch event
  • $200,000 in total funds to be awarded

Astellas Oncology Announces Grand Prize Winner of C3 Prize® at Union for International Cancer Control (UICC) World Cancer Congress

Summary: 
  • Three innovators working to change cancer care awarded a combined $100,000 in grants following live pitch to a panel of judges that included celebrity entrepreneur Bill Rancic.
     
  • Winning idea aims to change the way Nigerians learn and talk about breast cancer
Press Release
  • Three innovators working to change cancer care awarded a combined $100,000 in grants following live pitch to a panel of judges that included celebrity entrepreneur Bill Rancic.
     
  • Winning idea aims to change the way Nigerians learn and talk about breast cancer

Astellas Oncology Announces C3 Prize® Celebrity Partnership and Category Winners

Summary: 

Bill and Giuliana Rancic to Lend Expertise, Passion and Personal Cancer Experience to Inspire Fellow Entrepreneurs C3 Prize Category Winners will compete for the Grand Prize during a live event at the Union for International Cancer Control (UICC) World Cancer Control (UICC) World Cancer Congress on October 3 in Kuala Lumpur, Malaysia.

Press Release

Bill and Giuliana Rancic to Lend Expertise, Passion and Personal Cancer Experience to Inspire Fellow Entrepreneurs C3 Prize Category Winners will compete for the Grand Prize during a live event at the Union for International Cancer Control (UICC) World Cancer Control (UICC) World Cancer Congress on October 3 in Kuala Lumpur, Malaysia.

Astellas Oncology C3 Prize® Returns for Third Year with Focus on Improving Cancer Care in Underserved Regions of the World

2018 Challenge Will Award a Total of $100,000 in New Grants to Help Reduce the Unequal Burden of Cancer - All Healthcare Innovators Encouraged to Apply
Press Release

TOKYO, June 1, 2018 /3BL Media/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") have announced the launch of the third annual Astellas Oncology C3 Prize (Changing Cancer Care), a global challenge aimed at inspiring non-treatment ideas that may improve cancer care for patients and their loved ones. This year's challenge will focus on solutions for cancer care in low- and middle-income countries, which bear a disproportionate burden of the global cancer epidemic.1,2,3

Astellas To Present on Challenges to Health Innovation at Milken Institute Global Conference

Astellas Americas President Jim Robinson to discuss the importance of listening to patients in tackling health decision-making, financial burden and transparency in care
Press Release

NORTHBROOK, Ill., April 27, 2017 /3BL Media/ -- Astellas today announced that Astellas Americas President Jim Robinson will participate in a panel entitled "Getting Our Health Priorities in Order: Prevention, Research, and Treatment" from 8 – 9:15 a.m. PT Monday, May 1 at the 20th Annual Milken Institute Global Conference in Los Angeles.

Astellas Oncology Announces Winning C3 Prize™ Ideas in Virtual Reality, Online Patient Support and Fatigue-Reducing Light Therapy to Change Cancer Care

Three C3 Prize winners awarded a total of $100,000 in grants and a membership to MATTER
Press Release

NORTHBROOK, Ill., October 11, 2016 /3BL Media/ -- Astellas Oncology announced the three winners of the inaugural C3 Prize – a global challenge designed to acknowledge non-medicine innovations to improve the cancer care experience for patients, caregivers and their loved ones –  during the European Society of Medical Oncology (ESMO) Annual Congress in Copenhagen, Denmark  Friday, October 7.

Astellas Oncology Selects Five C3 Prize™ Finalists to Pitch Ideas for Changing Cancer Care to Panel Including Robert Herjavec at Stanford Medicine X

Out of more than 100 applicants from all over the world, five health care advocates with bright ideas to change cancer care will compete for a chance to win one of three grants totaling $100,000
Press Release

NORTHBROOK, Ill., September 12, 2016 /3BL Media/ -- Astellas today announced the five C3 Prize finalists chosen to present their ideas live at the Stanford Medicine X conference on Sept. 17 to a panel of judges including Robert Herjavec, dynamic entrepreneur, passionate cancer caregiver and star of ABC's Emmy Award-winning television show, Shark Tank. The C3 Prize is a challenge designed to inspire non-medicine innovations to improve the cancer care experience for patients, caregivers and their loved ones.

Astellas Oncology C3 Prize™ to Bring Bright Ideas in Cancer Care to Life with $100,000 in Grants

Finalists invited to pitch ideas to panel of judges including Robert Herjavec, technology entrepreneur, passionate cancer caregiver and star of ABC's Emmy Award-winning hit television show Shark Tank
Press Release

BOSTON, April 26, 2016 /3BL Media/ -- Astellas Pharma Inc. (TSE: 4503) announced today the launch of the C3 Prize™, a challenge designed to inspire non-medicine innovations that improve the cancer care experience for patients, caregivers and loved ones. Entries will be accepted through August 8 and following a live pitch to a panel of judges including Robert Herjavec, star of ABC's Emmy Award-winning hit television show Shark Tank, three winners will be awarded a total of $100,000 in grants as well as membership to healthcare technology incubator MATTER to bring their ideas to life.

Subscribe to C3 Prize